CDH5 and neoplasm: To further evaluate the vascular integrity in PAK4KO tumours, we employed multiplex immunofluorescence to assess the VE-cadherin expression as a marker of the vascular integrity in tumour tissues [39] We used cytokeratin 19 as a tumour cell marker and CD31 as an endothelial cell marker.